KLASS RUSSELL KEVIN (Vice President of Sales) purchased 25.1% of their position (1.06M shares) of ZOMEDICA CORP. on the open market
Open‑market purchase worth $42.2K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/13/2025ACC: 0001654954-25-009503
Officer· Vice President of Sales
Since Nov 2023
+1.06M
Net shares
Net buyer
$42.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1.06M acquired
Non-Derivative Transactions3
Common Stock, without par value
Direct
Shares
+60.72K
Price / share
$0.04
Trade value
$2.43K
% of position
1.4%
8/11/2025
4.20M→4.26M
Common Stock, without par value
Direct
Shares
+250K
Price / share
$0.04
Trade value
$10K
% of position
5.9%
8/12/2025
4.26M→4.51M
Common Stock, without par value
Direct
Shares
+745.34K
Price / share
$0.04
Trade value
$29.81K
% of position
16.5%
8/12/2025
4.51M→5.26M
Total
Net shares
+1.06M
Net value
$42.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, without par value Direct | 8/11/2025 | P · Purchase | +60.72K | $0.04 | $2.43K | 1.4% | 4.20M | 4.26M |
| Common Stock, without par value Direct | 8/12/2025 | P · Purchase | +250K | $0.04 | $10K | 5.9% | 4.26M | 4.51M |
| Common Stock, without par value Direct | 8/12/2025 | P · Purchase | +745.34K | $0.04 | $29.81K | 16.5% | 4.51M | 5.26M |
| Total | +1.06M | $42.24K | ||||||
Derivative Transactions0
No derivative transactions reported